Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Anna Gillio-TosFranco Merletti

Abstract

Infection with human papillomavirus (HPV) is a necessary step in the progression to cervical cancer. Many methods for HPV testing are currently available, most developed to detect pools of HPV types. To evaluate the HPV typing by molecular methods and to compare commercial kits with an established laboratory method. Eighty-four cervical samples found to be positive for HPV DNA by GP5+/6+-polymerase chain reaction-enzyme immunoassay-reverse line blotting (PCR-EIA-RLB) were re-tested with two commercial methods, INNO-LiPA and Amplisense HPV typing, able to identify the HPV type predicted by PCR-EIA-RLB in 76 and 67 samples, respectively. The INNO-LiPA assay revealed HPV DNA in 75/76 samples (98.7%; 95% CI, 0.93-0.99) that would contain HPV types identifiable by this assay. The Amplisense HPV assay revealed HPV DNA in 58/67 samples (86.6%; 95% CI, 0.76-0.93) containing HPV types detectable by this assay. For samples with a single infection, the unweighted kappa for concordance of HPV typing was 0.87 (95% CI, 0.78-0.97) for PCR-EIA-RLB versus INNO-LiPA, 0.94 (95% CI, 0.87-0.99) for INNO-LiPA versus Amplisense HPV, and 0.82 (95% CI, 0.70-0.94) for PCR-EIA-RLB versus Amplisense HPV typing. PCR-EIA-RLB revealed 12 multiple infections,...Continue Reading

References

Aug 19, 1991·International Journal of Cancer. Journal International Du Cancer·E A MorrisonR D Burk
Apr 20, 1994·JAMA : the Journal of the American Medical Association·T M BeckerM H Dorin
May 11, 1999·JAMA : the Journal of the American Medical Association·M M ManosR A Hiatt
Aug 19, 1999·The Journal of Pathology·J M WalboomersN Muñoz
Jul 16, 2002·American Journal of Epidemiology·Yolanda van der GraafJan van den Tweel
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Dec 20, 2003·Pharmacogenomics·Richard Obiso, Attila Lorincz
Dec 24, 2003·The Cancer Journal·Christopher P Crum, Miguel N Rivera

❮ Previous
Next ❯

Citations

May 27, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ming GuoNour Sneige
Mar 7, 2008·Journal of Clinical Microbiology·Ivan SabolRuth Tachezy
May 9, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Brian J Morris, Barbara R Rose
Jan 21, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A K KristoffersenB Grinde
Feb 4, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Nae-Fang TwuChing-Yu Lin
May 19, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Melissa Rodrigues de AraujoAnna Gillio-Tos
May 6, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ching-Yu LinChyong-Huey Lai
Sep 25, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Fatima Galan-Sanchez, Manuel A Rodriguez-Iglesias
Mar 19, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hae-Sun Chung, Miae Lee
May 18, 2013·Journal of Virological Methods·Elsa Herraez-HernandezJose Luis Rodriguez-Peralto
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Antonella AgodiSalvatore Travali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Nubia MuñozInternational Agency for Research on Cancer Multicenter Cervical Cancer Study Group
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Fátima Galan-Sanchez, Manuel Rodriguez-Iglesias
© 2022 Meta ULC. All rights reserved